AU2002210795A1 - Use of neutrophil inhibitory factor in combination with other thrombolytic or neuroprotective drugs for treating pathophysiological conditions involving neutrophils - Google Patents

Use of neutrophil inhibitory factor in combination with other thrombolytic or neuroprotective drugs for treating pathophysiological conditions involving neutrophils

Info

Publication number
AU2002210795A1
AU2002210795A1 AU2002210795A AU1079502A AU2002210795A1 AU 2002210795 A1 AU2002210795 A1 AU 2002210795A1 AU 2002210795 A AU2002210795 A AU 2002210795A AU 1079502 A AU1079502 A AU 1079502A AU 2002210795 A1 AU2002210795 A1 AU 2002210795A1
Authority
AU
Australia
Prior art keywords
thrombolytic
combination
inhibitory factor
conditions involving
pathophysiological conditions
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2002210795A
Other languages
English (en)
Inventor
Paul Butler
Suresh Babubhai Chahwala
Michael Chopp
Michael Krams
Michael Looby
Fion Macintyre
Andrew Brian Mcelroy
Aileen Dorothy Mcharg
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of AU2002210795A1 publication Critical patent/AU2002210795A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Zoology (AREA)
  • Epidemiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Virology (AREA)
  • Immunology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Pain & Pain Management (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Hematology (AREA)
  • Rheumatology (AREA)
  • Diabetes (AREA)
  • AIDS & HIV (AREA)
  • Molecular Biology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
AU2002210795A 2000-10-17 2001-10-15 Use of neutrophil inhibitory factor in combination with other thrombolytic or neuroprotective drugs for treating pathophysiological conditions involving neutrophils Abandoned AU2002210795A1 (en)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
GB0025473.0 2000-10-17
GBGB0025473.0A GB0025473D0 (en) 2000-10-17 2000-10-17 Pharmaceutical combinations
GB0025473 2000-10-17
PCT/IB2001/001936 WO2002032446A2 (en) 2000-10-17 2001-10-15 Use of neutrophil inhibitory factor in combination with other thrombolytic or neuroprotective drugs for treating pathophysiological conditions involving neutrophils

Publications (1)

Publication Number Publication Date
AU2002210795A1 true AU2002210795A1 (en) 2002-04-29

Family

ID=9901490

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2002210795A Abandoned AU2002210795A1 (en) 2000-10-17 2001-10-15 Use of neutrophil inhibitory factor in combination with other thrombolytic or neuroprotective drugs for treating pathophysiological conditions involving neutrophils

Country Status (13)

Country Link
US (1) US20020098179A1 (es)
AP (1) AP2001002295A0 (es)
AR (1) AR034698A1 (es)
AU (1) AU2002210795A1 (es)
DO (1) DOP2001000266A (es)
GB (1) GB0025473D0 (es)
GT (1) GT200100207A (es)
HN (1) HN2001000232A (es)
PA (1) PA8530701A1 (es)
PE (1) PE20020536A1 (es)
TN (1) TNSN01142A1 (es)
UY (1) UY26969A1 (es)
WO (1) WO2002032446A2 (es)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10153601A1 (de) * 2001-11-02 2003-05-22 Paion Gmbh DSPA zur Behandlung von Schlaganfall
US20030219431A1 (en) * 2002-05-24 2003-11-27 Empire Pharmaceuticals, Inc. Treatment of neuronal and neurological damage associated with spinal cord injury
CN1310949C (zh) * 2003-01-13 2007-04-18 重庆富进生物医药有限公司 具有抑制白细胞功能和凝血酶活性的双功能嵌合蛋白
CA2426115A1 (en) * 2003-04-18 2004-10-18 Victor Gurewich Methods, devices, and compositions for lysis of occlusive blood clots while sparing wound sealing clots
JP2008510835A (ja) * 2004-08-25 2008-04-10 エッセンシャリス，インク． カリウムａｔｐチャンネル開放因子の製剤処方、及びその使用
US20070167419A1 (en) * 2005-03-02 2007-07-19 The Regents Of The University Of California Treatment for embolic stroke
US20070166299A1 (en) * 2005-03-02 2007-07-19 The Regents Of The University Of California Treatment for embolic stroke
WO2006094120A2 (en) * 2005-03-02 2006-09-08 The Regents Of The University Of California Treatment for embolic stroke
PL1968601T3 (pl) 2006-01-05 2012-03-30 Essentialis Inc Sole związków otwierających kanały potasowe ATP i ich zastosowanie
CN101245110B (zh) * 2007-02-16 2010-09-15 鲁南制药集团股份有限公司 重组中性粒细胞抑制因子和水蛭原嵌合蛋白及其药物组合物
AU2008272923A1 (en) * 2007-07-02 2009-01-08 Essentialis, Inc. Salts of potassium ATP channel openers and uses thereof
TWI482628B (zh) * 2007-10-18 2015-05-01 Lundbeck & Co As H 新穎之血栓溶解病患次群
JP6005514B2 (ja) 2009-06-10 2016-10-12 ノノ インコーポレイテッド 神経疾患の治療のためのモデル系及び治療計画
KR102425466B1 (ko) * 2011-06-24 2022-07-25 노노 인코포레이티드 허혈에 대한 psd-95 억제제와의 조합 요법
US9241970B2 (en) 2011-12-13 2016-01-26 Nono Inc. Therapy for subarachnoid hemorrhage and ischemia
CA2966332C (en) 2014-11-03 2024-04-16 Thrombolytic Science, Llc Methods and compositions for safe and effective thrombolysis
US10336827B2 (en) 2015-10-29 2019-07-02 Wayne State University Compositions and methods to treat solid tumors
WO2018232305A1 (en) 2017-06-16 2018-12-20 Thrombolytic Science, Llc Methods and compositions for thrombolysis
EP4248954A4 (en) * 2020-11-17 2024-06-26 Talengen International Limited METHODS AND DRUGS TO INCREASE BDNF LEVELS
AU2022289008A1 (en) * 2021-06-09 2023-12-21 Proniras Corporation Methods of treating or preventing conditions associated with opiate withdrawal or opiate relapse

Also Published As

Publication number Publication date
PA8530701A1 (es) 2003-06-30
HN2001000232A (es) 2002-04-22
TNSN01142A1 (fr) 2005-11-10
WO2002032446A3 (en) 2002-07-11
PE20020536A1 (es) 2002-06-20
DOP2001000266A (es) 2002-05-31
US20020098179A1 (en) 2002-07-25
AR034698A1 (es) 2004-03-17
GT200100207A (es) 2002-08-19
GB0025473D0 (en) 2000-11-29
AP2001002295A0 (en) 2001-12-31
UY26969A1 (es) 2002-06-20
WO2002032446A2 (en) 2002-04-25

Similar Documents

Publication Publication Date Title
AU2002210795A1 (en) Use of neutrophil inhibitory factor in combination with other thrombolytic or neuroprotective drugs for treating pathophysiological conditions involving neutrophils
AU2002211340A1 (en) Systems and methods for preventing and/or reducing corrosion in various articles
EP1487492A4 (en) PREVENTION OR TREATMENT OF CANCER USING INTEGRIN ALPHAVBETA3 ANTAGONISTS COMBINED WITH OTHER AGENTS
IL173990A0 (en) 2-pyridone derivatives as neutrophil elastase inhibitors and their use
TW479766U (en) Rack and pinion type swinging actuator
HK1049643A1 (zh) 一種具有多層膜的反射體及其製造方法
AU2221801A (en) Glass for use in freezer/refrigerator and glass article using said glass
AU2002225688A1 (en) Integrated graphics processing unit with antialiasing
AU2001272788A1 (en) Parallel z-buffer architecture and transparency
AU2001276959A1 (en) Methods, system, and article for displaying privilege state data
AU5289300A (en) Detection of wear-particles and other impurities in industrial or other fluids
AU4289100A (en) Dihydropyrimidines and their use in the treatment of hepatitis
AU5073100A (en) Pyridine carboxamides and their use as plant protection agents
AU2001249626A1 (en) Cathepsin inhibitors in cancer treatment
AU2002211789A1 (en) Cathodic protection of steel in reinforced concrete with electroosmotic treatment
AU7475000A (en) Retroreflective articles having multilayer films and methods of manufacturing same
AU2001276027A1 (en) Heteroaryl-beta-alanine derivatives as alpha 4 integrin inhibitors
AU2003274905A1 (en) Recombinant double-stranded rna phage, and use of the same
AU2001271483A1 (en) Method for imaging inclusions and/or alpha case in articles
AU2001237025A1 (en) Antimicrobial composition and articles
EP1108802A4 (en) STAINLESS STEEL MATERIAL WITH EXCELLENT ANTIBACTERIAL PROPERTIES AND METHOD FOR THE PRODUCTION THEREOF
AU2001281246A1 (en) Benzimidazoles and analogues and their use as neutrophil inhibitors
AU5220800A (en) Combination of mtp inhibitors and lipid reducers and the use thereof in medicaments
AU2002348534A1 (en) Materials and methods for preventing or reducing scar formation
AU2002338996A1 (en) Delivery system for consumption and/or spare parts